Table 1 Baseline demographic, anthropometric and laboratory parameters and the used cardiovascular medication of the patients

N (male:female)

24 (9:15)

24 (9:15)

Age (year)

63.7 ± 2.54

64.3 ± 2.52

Body height (cm)

164.5 ± 1.51

166 ± 2.06

Body weight (kg)

76.3 ± 2.66

81 ± 3.34

AC (cm)

101.5 ± 4.1

102 ± 5.5

BMI (kg/m²)

28.2 (26–31.2)

29.8 (24.4–34.6)

Glucose (mmol/l)

5.36 (5.03–6.07)

5.7 (4.94–6.63)

CKD-EPI GFR (mmol/l)

77.5 (62.5–86)

78.5 (60.8–90)

Uric acid (µmol/l)

309.3 ± 15.26

321.6 ± 16.82

Cholesterol (mmol/l)

5.48 ± 0.22

5 ± 0.35

Triglyceride (mmol/l)

1.36 (1.08–2.18)

1.82 (0.99–2.15)

BDNF (ng/ml)

27.29 (24.2–30.35)

20.10 (14.74–27.11)*

ACE-inhibitors [n (%)]

13 (54.2)

13 (54.2)

ARBs

9 (37.5)

5 (20.8)

Calcium-channel blockers

11 (45.8)

11 (45.8)

Beta-blockers

12 (50)

18 (75)*

Diuretics

11 (45.8)

11 (45.8)

Antiplatelet medication

8 (33.3)

11 (45.8)